Futura Medical is an innovative R&D company with a pipeline of products in late-stage development. We are experts in topical formulations and transdermal delivery and have developed an advanced proprietary, transdermal drug delivery technology, DermaSys®.

Our strategy is to develop our innovative product portfolio to late-stage and then partner at the optimum time to generate most value. 

We are based in Guildford, UK and are listed on the AIM market of the London Stock Exchange.